(0.19%) 5 141.00 points
(0.16%) 38 502 points
(0.25%) 17 891 points
(-0.97%) $83.04
(1.72%) $1.956
(-0.17%) $2 343.20
(0.87%) $27.49
(0.25%) $924.40
(-0.22%) $0.933
(-0.19%) $11.00
(-0.25%) $0.798
(1.04%) $92.83
Live Chart Being Loaded With Signals
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States...
Stats | |
---|---|
本日の出来高 | 17 402.00 |
平均出来高 | 23 884.00 |
時価総額 | 41.06M |
EPS | $0 ( 2024-03-28 ) |
次の収益日 | ( $-0.360 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.840 |
ATR14 | $0.0450 (1.35%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-01 | Milligan Sandra | Buy | 0 | |
2024-02-15 | Sandford Nicole | Buy | 30 000 | Employee stock option (right to buy) |
2024-02-14 | Hombeck Torsten | Buy | 20 000 | Employee stock option (right to buy) |
2024-02-14 | Merchant Minh Hoang | Buy | 11 000 | Employee stock option (right to buy) |
2024-01-26 | Sandford Nicole | Buy | 2 400 | Common Stock |
INSIDER POWER |
---|
97.20 |
Last 89 transactions |
Buy: 4 429 531 | Sell: 195 424 |
Aspira Women's Health 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Aspira Women's Health 財務諸表
Annual | 2023 |
収益: | $9.15M |
総利益: | $5.26M (57.48 %) |
EPS: | $-1.810 |
FY | 2023 |
収益: | $9.15M |
総利益: | $5.26M (57.48 %) |
EPS: | $-1.810 |
FY | 2022 |
収益: | $8.18M |
総利益: | $4.32M (52.77 %) |
EPS: | $-41.66 |
FY | 2021 |
収益: | $6.81M |
総利益: | $3.06M (44.95 %) |
EPS: | $-0.280 |
Financial Reports:
No articles found.
Aspira Women's Health
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gynecologic cancer. In addition, the company operates Aspira Synergy, a testing platform and cloud service for decentralized access of protein biomarker and hereditary genetic testing; and owns and operates ASPiRA LABS, a lab that specializes in applying biomarker-based technologies to address critical needs in the management of gynecologic cancers and disease. Further, its pipeline products include OVAWatch, EndoCheck, and OVAInherit. The company serves physicians, physician office laboratories, and national and regional laboratories. It has a collaborative research agreement with Baylor Genetics; an agreement with Harvard Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Medical University Lodz to evaluate the microRNA technology in combination with Aspira technologies for the development of an early detection test for ovarian cancer; and a strategic alliance with Quest Diagnostics, Incorporated. The company was formerly known as Vermillion, Inc. and changed its name to Aspira Women's Health Inc. in June 2020. Aspira Women's Health Inc. was incorporated in 1993 and is headquartered in Austin, Texas.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。